{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:48:19Z","timestamp":1785541699458,"version":"3.56.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773635"],"award-info":[{"award-number":["81773635"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073765"],"award-info":[{"award-number":["82073765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["19431900500"],"award-info":[{"award-number":["19431900500"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["20S11902400"],"award-info":[{"award-number":["20S11902400"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejmech.2021.113585","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T03:02:20Z","timestamp":1622516540000},"page":"113585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Discovery of novel N-sulfonamide-tetrahydroisoquinolines as potent retinoic acid receptor-related orphan receptor \u03b3t agonists"],"prefix":"10.1016","volume":"222","author":[{"given":"Xiaojun","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113585_bib1","first-page":"261","article-title":"Beyond death and dying: how Chinese spouses navigate the final days with their loved ones suffering from terminal cancer, Support","volume":"26","author":"Chung","year":"2018","journal-title":"Care Cancer"},{"key":"10.1016\/j.ejmech.2021.113585_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.it.2020.04.004","article-title":"Opportunities for small molecules in cancer immunotherapy","volume":"41","author":"van der Zanden","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ejmech.2021.113585_bib3","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.chembiol.2017.08.019","article-title":"Small-molecule targets in immuno-oncology","volume":"24","author":"Dhanak","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113585_bib4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1021\/acschembio.5b00899","article-title":"Synthetic ROR\u03b3t agonists enhance protective immunity","volume":"11","author":"Chang","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113585_bib5","doi-asserted-by":"crossref","unstructured":"E. Cash, S. Sephton, C. Woolley, A.M. Elbehi, A. R I, B. Ekine-Afolabi, V.C. Kok, The role of the circadian clock in cancer hallmark acquisition and immune-based cancer therapeutics, Journal of experimental & clinical cancer research CR 40, p. 119.","DOI":"10.1186\/s13046-021-01919-5"},{"issue":"14","key":"10.1016\/j.ejmech.2021.113585_bib6","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1021\/acs.jmedchem.7b01314","article-title":"Retinoic acid receptor-related orphan receptor \u03b3t (ROR\u03b3t) agonists as potential small molecule therapeutics for cancer immunotherapy","volume":"61","author":"Qiu","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113585_bib7","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1021\/jm401901d","article-title":"Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-\u03b3 (ROR\u03b3 or RORc)","volume":"57","author":"Fauber","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113585_bib8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1074-7613(00)80645-7","article-title":"ROR\u03b3t, a novel isoform of an orphan receptor, negatively regulates fas ligand expression and IL-2 production in T cells","volume":"9","author":"He","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2021.113585_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0378-1119(96)00504-5","article-title":"Cloning of a cDNA encoding the murine orphan receptor RZR\/ROR\u03b3 and characterization of its response element","volume":"181","author":"Alexander","year":"1996","journal-title":"Gene"},{"key":"10.1016\/j.ejmech.2021.113585_bib10","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113585_bib11","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4049\/jimmunol.179.3.1423","article-title":"Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression","volume":"179","author":"Kryczek","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2021.113585_bib12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood-2009-03-208249","article-title":"Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments","volume":"114","author":"Kryczek","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2021.113585_bib13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.immuni.2009.09.014","article-title":"T\u00a0helper 17 cells promote cytotoxic T cell activation in tumor immunity","volume":"31","author":"Martin-Orozco","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2021.113585_bib14","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/cmdc.201600491","article-title":"N-arylsulfonyl indolines as retinoic acid receptor-related orphan receptor \u03b3 (ROR\u03b3) agonists","volume":"11","author":"Doebelin","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113585_bib15","doi-asserted-by":"crossref","first-page":"127204","DOI":"10.1016\/j.bmcl.2020.127204","article-title":"Substituted benzyloxytricyclic compounds as retinoic acid-related orphan receptor gamma t (ROR\u03b3t) agonists","author":"Harikrishnan","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113585_bib16","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1158\/1078-0432.CCR-18-3185","article-title":"Phase 1 open-label, multicenter study of first-in-class ROR\u03b3 agonist LYC-55716 (cintirorgon): safety, tolerability, and preliminary evidence of antitumor activity","volume":"25","author":"Mahalingam","year":"2019","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113585_bib17","doi-asserted-by":"crossref","first-page":"111589","DOI":"10.1016\/j.ejmech.2019.111589","article-title":"Discovery of aryl-substituted indole and indoline derivatives as ROR\u03b3t agonists","volume":"182","author":"Zhu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113585_bib18","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1186\/s12900-016-0059-3","article-title":"Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand","volume":"16","author":"Marcotte","year":"2016","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.ejmech.2021.113585_bib19","series-title":"Lyc-55716: A Novel Small-Molecule ROR\u03b3 Agonist Immuno-Oncology Agent: Rationale for Tumor Selection and Clinical Evaluation of Gastric and Esophageal Carcinoma in Phase 2a Expansion","author":"Weems","year":"2018"},{"key":"10.1016\/j.ejmech.2021.113585_bib20","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1158\/1078-0432.CCR-18-3185","article-title":"Phase 1 open-label, multicenter study of first-in-class ROR\u03b3 agonist LYC-55716 (cintirorgon): safety, tolerability, and preliminary evidence of antitumor activity","volume":"25","author":"Mahalingam","year":"2019","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113585_bib22","series-title":"Benzoxazine, Aza-Benzoxazine, and Related Bicyclic Compounds for Inhibition of RORgamma Activity and the Treatment of Disease","author":"Thomas D","year":"2015"},{"key":"10.1016\/j.ejmech.2021.113585_bib23","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1021\/ml500420y","article-title":"Minor structural change to tertiary sulfonamide RORc ligands led to opposite mechanisms of action","volume":"6","author":"Ren\u00e9","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113585_bib24","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1016\/j.bmcl.2014.06.048","article-title":"Reduction in lipophilicity improved the solubility, plasma-protein binding, and permeability of tertiary sulfonamide RORc inverse agonists","volume":"24","author":"Fauber","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113585_bib25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1021\/acs.jmedchem.8b01181","article-title":"Design, synthesis, and biological evaluation of retinoic acid-related orphan receptor \u03b3t (ROR\u03b3t) agonist structure-based functionality switching approach from in house ROR\u03b3t inverse agonist to ROR\u03b3t agonist","volume":"62","author":"Yukawa","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113585_bib26","first-page":"113013","article-title":"Discovery of tetrahydroquinolines and benzomorpholines as novel potent ROR\u03b3t agonists","author":"Xia","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113585_bib27","series-title":"Aromatic Amide Derivative, Preparation Method Therefor, and Pharmaceutical Applications Thereof","author":"Jun","year":"2017"},{"key":"10.1016\/j.ejmech.2021.113585_bib28","doi-asserted-by":"crossref","first-page":"111984","DOI":"10.1016\/j.ejmech.2019.111984","article-title":"Discovery of novel N-sulfonamide-tetrahydroquinolines as potent retinoic acid receptor-related orphan receptor \u03b3t inverse agonists for the treatment of autoimmune diseases","volume":"187","author":"Sun","year":"2020","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421004347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421004347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:28:46Z","timestamp":1759328926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421004347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":27,"alternative-id":["S0223523421004347"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113585","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel N-sulfonamide-tetrahydroisoquinolines as potent retinoic acid receptor-related orphan receptor \u03b3t agonists","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113585"}}